Introducing Koala Prospector! Bringing Waterfall Enrichment to Reps

Learn More!
Biochimpharm

Biochimpharm

For decades, we have been deploying bacteriophage technology to create natural, safe and effective preparations. Nowadays, phage preparations are the only viable alternative to antibiotics. Our products are effectively used for treatment and prevention of infections caused by resistant bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA). Unlike other antimicrobial preparations, such as antibiotics, phages selectively eliminate disease-causing bacteria without harming the beneficial microflora of human body. Phages do not have any contraindications or side effects, such as adverse effects on liver and kidneys, dysbacteriosis and other problems ensuing from antibiotic use. Biochimpharm is founded on a scientific and technological basis of Eliava Institute of Bacteriophages, which had been providing all of the Soviet Union and Eastern Europe with phages for fifty years. We are drawing on one hundred years of accumulated experience in research and manufacture of phages. Biochimpharm is one of the world leaders in the field of bacteriophage technology; Its coverage area extending year by year. Vison and mission

Last updated on

About Biochimpharm

Founded

1999

Estimated Revenue

$10M-$50M

Employees

51-250

Category

Industry

Biotechnology

Location

State

T'bilisi

Country

Georgia

Tech Stack (0)

search